What Vitrolife does

Vitrolife AB (publ) is a Swedish publicly listed biotechnology company headquartered in Västra Frölunda, Gothenburg, that develops, manufactures and sells integrated products, consumables, software and services for the global in vitro fertilisation (IVF) and assisted reproductive technology (ART) market. Founded around 1981/1996 and operating under the Vitrolife Group corporate umbrella alongside the acquired Igenomix genetics brand, the company organises its offering around the seven-step IVF journey — oocyte retrieval, sperm preparation, fertilisation (IVF/ICSI), embryo culture, evaluation, embryo transfer and cryopreservation — and is one of the few vendors that can supply a clinic with a fully integrated stack from oocyte retrieval needles through to cryostorage monitoring.

The technical core is a hardware-plus-software platform: the EmbryoScope/EmbryoScope+/EmbryoScope Flex time-lapse incubators and CulturePro incubator feed the EmbryoViewer workstation software, which embeds proprietary AI capabilities (iDAScore for embryo ranking and AI-based Guided Annotation), KIDScore decision support, Compare & Select tools, and integrates with the eWitness electronic witnessing system and Octax laser for biopsy. Consumables include the G-Series and antioxidant-enriched Gx-Series embryo culture media, ICSI medium, HYASE-10x, MicroCell sperm-processing consumables, VitroTemp, OVOIL and OVOIL HEAVY culture oils, micromanipulation pipettes, oocyte retrieval needles, EmbryoGlue hyaluronan-enriched transfer medium (backed by two Cochrane meta-analyses), the Rapid-i vitrification system with RapidVit/RapidWarm media kits and the Ultra RapidWarm Blast protocol, plus FreezeKit/ThawKit cleave and B:safe/Log & Guard cryostorage monitoring. Vitrolife also offers genomics kits and the EMBRACE non-invasive PGT-A protocol through its Igenomix subsidiary.

The business model combines recurring consumables revenue (usage-based, +9% in Q1 2026) with capital equipment and software sales (Technologies segment, +11% in Q1 2026) and professional services revenue from genomics and the Vitrolife Group Academy (workshops GO/PRO/FLEX and Academy Online). Q1 2026 sales were SEK 807 million with gross margin of 59.9%. Pricing is quote-based and hidden behind customer login on a 24/7 webshop; go-to-market mixes direct field sales to IVF clinics, a global distributor/reseller network, event-driven congress engagement (e.g., ESHRE booth C07 in London, July 2026), and a community-led Academy ecosystem that drives protocol standardisation and consumables pull-through. The company employs 1,001–5,000 staff, serves markets across Europe, North America, APAC and the Middle East, and is publicly listed (OTC: VTRLY; Nasdaq Stockholm: VITR).

Name

Vitrolife

Legal name

Vitrolife AB

Website

https://vitrolife.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vitrolife is a Swedish public biotechnology company that develops integrated hardware, AI-based embryo evaluation software and consumables for IVF clinics worldwide, covering the full assisted reproductive technology workflow from oocyte retrieval to cryopreservation.

Ownership category

akta.pro rank

Product category

Assisted Reproductive Technology (IVF) Products and Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• IVF laboratory products
• Assisted reproduction technology
• Embryo culture media
• Time-lapse incubation systems
• Reproductive genomics services

Headquarters

HQ city

Frölunda

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Consumables product sales: Recurring revenue from single-use IVF consumables including culture media (G-Series, Gx-Series), OVOIL / OVOIL HEAVY overlay oils, EmbryoGlue transfer medium, sperm processing products, oocyte retrieval needles, micromanipulation pipettes, labware, vitrification/warming kits and cryopreservation consumables. The Consumables segment grew +9% in Q1 2026.
2. Technologies / capital equipment sales: One-time and recurring equipment sales plus service revenue from EmbryoScope / EmbryoScope+ / EmbryoScope Flex time-lapse incubators, eWitness electronic witnessing, Octax laser and imaging systems, and B:safe / Log & Guard cryostorage monitoring. The Technologies segment grew +11% in Q1 2026.
3. Genomics / genetic testing services: Genomics kits and preimplantation genetic testing services (PGT-A, PGT-M) including the EMBRACE non-invasive PGT-A protocol; Vitrolife announced restructuring of genetic services in December 2025, discontinuing two test lines and exiting low-profit markets to save SEK 65 million annually.
4. Academy, training and educational services: Revenue derived indirectly via Vitrolife Group Academy (workshops: Academy GO, PRO and FLEX), Vitrolife Group Academy Online e-learning, and customized clinical support that drives consumables and equipment pull-through.

Pricing tiers

Go-to-market motion5 records

Distribution channels5 records

Marketing channels8 records

Core offering

Vitrolife provides an integrated portfolio of products and services that span the complete IVF laboratory workflow, including time-lapse incubation systems (EmbryoScope+), AI-based embryo evaluation software (iDAScore, EmbryoViewer), electronic witnessing (eWitness), embryo culture media (G-Series, Gx-Series), overlay oils (OVOIL, OVOIL HEAVY), embryo transfer medium (EmbryoGlue), vitrification systems (Rapid-i), cryostorage monitoring (B:safe, Log & Guard), micromanipulation tools (Octax laser, pipettes), and genomics kits for preimplantation genetic testing. The company sells these to IVF clinics and fertility centers worldwide.

Product overview

Vitrolife offers a platform-plus-modules architecture for the IVF journey, organised around the seven clinical steps (oocyte retrieval → sperm preparation → fertilisation IVF/ICSI → culture → evaluation → embryo transfer → cryopreservation). The time-lapse hardware layer (EmbryoScope+, EmbryoScope, EmbryoScope Flex and CulturePro incubators) is paired with the EmbryoViewer software suite, which embeds AI-based tools such as iDAScore (embryo ranking) and Guided Annotation, supported by KIDScore and Compare & Select, and integrated with the eWitness electronic witnessing system and Octax laser/imaging for biopsy. Consumables cover the full workflow: G-Series and Gx-Series (antioxidant-enriched) culture media, OVOIL and OVOIL HEAVY oil overlays, ICSI medium and HYASE-10x, sperm-processing consumables such as MicroCell, and VitroTemp for off-incubator temperature checks. The cryopreservation portfolio centres on the Rapid-i Vitrification System with RapidVit/RapidWarm media kits and the Ultra RapidWarm Blast protocol, plus FreezeKit cleave/ThawKit cleave for slow freezing, and is supported by B:safe and Log & Guard cryostorage monitoring. Embryo transfer is anchored by EmbryoGlue hyaluronan-enriched medium, and Vitrolife Genomics together with the EMBRACE non-invasive PGT-A protocol extends the platform into preimplantation genetic testing, with educational services delivered through the Vitrolife Academy Online platform.

Differentiator

Problem solved

Functional benefit

Brands

• Igenomix: Reproductive genetics and genetic testing services for IVF, operated as part of Vitrolife Group following the 2021 acquisition.

Products and services

• EmbryoScope+ time-lapse incubator Time-lapse incubator that captures continuous embryo development images, used with EmbryoSlide+ culture dishes and the EmbryoViewer/iDAScore software stack for non-disruptive embryo evaluation in IVF labs.
• EmbryoScope time-lapse incubator Time-lapse incubator loaded with EmbryoSlide culture dishes, used for uninterrupted embryo culture and time-lapse imaging in IVF labs.
• EmbryoScope Flex time-lapse incubator Time-lapse incubator variant used with EmbryoSlide Flex culture dishes for flexible embryo culture and imaging workflows.
• CulturePro incubator Incubator used with CulturePro dishes for embryo culture in the IVF lab.
• EmbryoViewer software Workstation software for inspecting and analyzing embryo time-lapse data, registering patient data, visualising incubation conditions, and exporting data; includes Guided Annotation (AI-based), KIDScore decision support, Compare & Select, and information-model tools.
• iDAScore AI embryo evaluation software Proprietary AI software that automatically analyzes time-lapse embryo images and ranks embryos by implantation potential, helping embryologists select embryos for transfer and cryopreservation more consistently while saving time.
• eWitness electronic witnessing system Electronic witnessing system that fully integrates with the EmbryoScope+ to safeguard all gamete and embryo handling steps in the IVF lab.
• Octax laser and imaging systems Laser system used for assisted hatching and embryo biopsy (e.g., trophectoderm biopsy for PGT) in IVF labs.
• Rapid-i Vitrification System Closed vitrification system used with RapidVit/RapidWarm media for cryopreservation and warming of oocytes and embryos at all cell stages.
• RapidVit / RapidWarm media (Oocyte, Blast, Omni) Vitrification and warming media kits for the Rapid-i system used to cryopreserve and warm oocytes, blastocysts, and embryos at all cell stages.
• Ultra RapidWarm Blast Ultra-fast warming protocol and kit for safely and effectively warming cryopreserved blastocysts, designed to improve workflow efficiency while maintaining consistent high-quality results in the ART lab.
• FreezeKit cleave / ThawKit cleave Slow-freezing and thawing kits for cryopreservation of cleavage-stage embryos.
• G-Series media (G-1 PLUS, G-2 PLUS, G-MOPS PLUS, G-TL) Sequential embryo culture media system used from post-fertilisation through blastocyst stage, together with OVOIL overlay and G-MOPS PLUS handling medium.
• Gx-Series media (Gx-TL, Gx-MOPS PLUS) Single-step embryo culture media containing a unique combination of three antioxidants (acetyl-L-carnitine, N-acetyl-L-cysteine and α-lipoic acid) intended to combat oxidative stress and improve embryo viability.
• ICSI medium and HYASE-10x Media used for ICSI procedures, with HYASE-10x as a hyaluronidase for cumulus/oocyte handling per Gx-Series and G-Series short protocols.
• EmbryoGlue embryo transfer medium Hyaluronan-enriched embryo transfer medium developed to mimic uterine conditions and improve implantation and live-birth rates; the most documented embryo transfer medium in IVF, part of two Cochrane meta-analyses.
• OVOIL IVF culture oil 100% light paraffin oil for covering embryo culture media during IVF and micromanipulation procedures; sterile filtered and rigorously quality tested (REF 10029, 1 x 100 mL).
• OVOIL HEAVY high-viscosity IVF culture oil World's first synthetic high-viscosity paraffin oil specifically developed, manufactured and certified for clinical IVF; reduces evaporation and helps safeguard osmolality and pH during uninterrupted culture (REF 10174).
• MicroCell sperm processing consumable Disposable counting chamber for accurate semen analysis; two or four samples can be assessed on each MicroCell.
• VitroTemp temperature measurement device Device used to measure the temperature of a medium in a dish during manipulations outside the incubator.
• EmbryoSlide+, EmbryoSlide, EmbryoSlide Flex culture dishes Single-use culture dishes designed for use with EmbryoScope+, EmbryoScope, and EmbryoScope Flex time-lapse incubators.
• CulturePro dishes Dishes used inside the CulturePro incubator for embryo culture.
• B:safe LN2 dewar monitoring trolley Non-invasive monitoring trolley for LN2 dewars with an integrated scale (filling level and evaporation rate) and an external surface temperature sensor for early vacuum-loss detection; alerts via Log & Guard network.
• Log & Guard cold-storage monitoring system Continuous monitoring system and controller for liquid nitrogen dewars and B:safe units, alerting clinic staff via SMS or controller-attached equipment when temperature or level limits are exceeded.
• Vitrolife Genomics PGT-A kits Genomics kits for preimplantation genetic testing (PGT-A), supported by Illumina Infinium assay workflows; non-invasive PGT-A delivered via the EMBRACE protocol together with EmbryoScope+ and iDAScore.
• EMBRACE non-invasive PGT-A protocol Vitrolife's non-invasive PGT-A protocol implemented in the laboratory with EmbryoScope+ and iDAScore to adapt to specific workflows and circumstances.
• Micromanipulation pipettes Pipettes for micromanipulation procedures including ICSI and embryo biopsy.
• Oocyte retrieval needles Needles used for oocyte retrieval during IVF procedures.

Quantifiable outcome

• EmbryoGlue associated with one additional live birth per 14 embryo transfers (Cochrane NNT) — ~20% increase in live births for a clinic with 700 cycles annually
• +4 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Partnerships

Five partnerships are on record, tiered core, minor and flagship.

• PureHealth / SEHA (Corniche Fertility Centre)coreGTM or Marketing Partner · 25 May 2026SEHA (a PureHealth subsidiary) deployed Vitrolife's iDAScore AI embryo selection at its Corniche Fertility Centre — the first AI embryo selection implementation within the PureHealth network in the UAE — establishing a flagship regional AI-ART reference customer.
• Deloitte ABminorImplementation/ SI/ Consulting Partner · 5 May 2026Deloitte AB was re-elected as auditor of Vitrolife AB at the May 5, 2026 Annual General Meeting, providing independent audit services for the group's 2025 income statements and balance sheets.
• EmbryotoolscoreStrategic or Co-development Partner · 9 October 2025Embryotools is Vitrolife's co-development and training partner, specialised in research, quality control, IVF training and consulting. They co-deliver the Academy PRO 'Blastocyst culture, biopsy and vitrification' workshop and supply comparative research data used in Vitrolife's OVOIL HEAVY white papers.
• IgenomixflagshipStrategic or Co-development Partner · 15 July 2021In July 2021 Vitrolife AB announced the acquisition of Igenomix for EUR 1.25 billion, expanding its business into reproductive genetic testing services. Igenomix is now part of the Vitrolife Group brand portfolio (vitrolifegroup.com lists Igenomix alongside Vitrolife).
• IlluminacoreTechnology or IntegrationVitrolife's Genomics kits product line is built on Illumina's Infinium chemistry; the Academy educational material links to Illumina Infinium e-learning, best-practices videos and controls training, indicating a deep technology and training integration with Illumina's genotyping platform.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• CooperSurgical: CooperSurgical (a CooperCompanies business) is one of the largest global suppliers of IVF consumables, micromanipulation tools, and ART lab equipment (Wallace, Research Instruments, Genesis Genetics), competing directly with Vitrolife across culture media, pipettes, and labware, but as part of a much broader women's-health portfolio.
• Merck KGaA (Life Science / Sigma-Aldrich): Merck KGaA's Life Science division sells IVF-grade culture media, supplements, and lab consumables (Sigma-Aldrich, EmbryoMax) that overlap with Vitrolife's G-Series/Gx-Series media portfolio, and it has the scale and distribution to bundle broadly with research and pharma customers.
• Thermo Fisher Scientific (Life Sciences): Thermo Fisher provides a broad range of IVF and reproductive-health lab products (media, reagents, equipment, cryopreservation supplies, genomics) that overlap with multiple parts of Vitrolife's consumables and genomics kits portfolio through brands like Gibco and Thermo Scientific.

Direct peers

• FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a leading global manufacturer of cell culture media and ART products (including Continuous Single Culture media), directly competing with Vitrolife's G-Series/Gx-Series culture media, OVOIL oils, and broader IVF consumables portfolio.
• Hamilton Thorne: Hamilton Thorne is a specialist ART and reproductive-science equipment provider (laser systems, time-lapse, micromanipulation tools), competing directly with Vitrolife's Octax laser, EmbryoScope time-lapse, and micromanipulation pipette lines in IVF labs globally.
• Genea Biomedx: Genea Biomedx develops integrated ART lab equipment and consumables (Geri time-lapse incubator, Gems culture media, Genea Biomedx pipettes) and is one of the closest direct competitors to Vitrolife's integrated IVF workflow stack.
• Kitazato Corporation: Kitazato is a Japanese specialist in IVF vitrification and cryopreservation, with the Cryotop system directly competing against Vitrolife's Rapid-i vitrification platform and RapidVit/RapidWarm media kits globally.
• Esco Medical: Esco Medical produces time-lapse IVF incubators (MIRI TL), ART workstations, and IVF lab equipment, directly competing with Vitrolife's EmbryoScope/EmbryoScope+ time-lapse incubation systems in clinics worldwide.
• Rocket Medical plc: Rocket Medical manufactures ART and fetal medicine devices including oocyte retrieval needles, embryo transfer catheters, and IUI/IVF consumables that compete directly with Vitrolife's oocyte retrieval needle and micromanipulation consumable lines.
• NidaCon International AB: NidaCon International (Sweden) is a niche IVF consumables specialist offering sperm preparation and cryopreservation products (e.g., SpermFilter, SpermSlow), overlapping with portions of Vitrolife's sperm processing and cryopreservation consumable lines and headquartered in the same Nordic region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vitrolifeivf
• Facebookfacebook.com/vitrolife
• LinkedInlinkedin.com/company/vitrolife

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitrolife